Active Ingredient: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG;200MG;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203053
Product Number: 001
Approval Date: Jan 24, 2022
Applicant Holder Full Name: HETERO LABS LTD UNIT V
Marketing Status:
Prescription
Patent and Exclusivity Information